Metabolite Impurity Reference Standards
This category focuses on various metabolites generated after drugs undergo biotransformation (such as liver metabolism) in the body. Although strictly speaking, they are in vivo products, in drug development and quality control, reference standards are often required for in vitro simulation studies or as known impurities for monitoring. We provide a range of reference standards, including phase I metabolites (such as hydroxylation and dealkylation products) and phase II metabolic conjugates. These reference standards are key tools for studying drug metabolic pathways, conducting safety assessments of metabolites (such as the MIST guidelines), and establishing analytical methods for biological samples. The product data is comprehensive (NMR, LC-MS/MS), helping you gain a deeper understanding of drug behavior in the body, assess the potential toxicity risks of metabolites, and ensure the scientific and regulatory compliance of new drug development and generic drug evaluation.



